ATS 2019 Virtual Final Program

Facilitator : S.C. Mathai, MD, MHS, Baltimore, MD P996 Additional Role of Echocardiogram in Pulmonary Arterial Hypertension Risk Stratification According to Current ESC/ERS Guidelines/ F. Dardi, A. Manes, M. Palazzini, E. Gotti, A. Rinaldi, A. Albini, E. Zuffa, D. Guarino, A. De Lorenzis, F. Pasca, I. Magnani, M. Rotunno, N. Galiè, Bologna, Italy, p.A3651 P997 Gender Impact on 30-Day Readmissions After Pulmonary Artery Hypertension-Related Hospitalization/ A.M. Abdul Hameed, S. Bhattacharya, J. Chirinos, S. Chatterjee, J. Giri, S.M. Kawut, J.A. Mazurek, P. Bhattacharya, Darby, PA, p.A3652 P998 Effect of Pulmonary Arterial Hypertension Specific Therapy in the Four Clinical Subgroups of Patients with Pulmonary Arterial Hypertension Associated with Congenital Heart Disease/ M. Palazzini, A. Manes, F. Dardi, E. Gotti, A. Rinaldi, A. Cassani, E. Zuffa, D. Guarino, A. De Lorenzis, F. Pasca, I. Magnani, M. Rotunno, N. Galié, Bologna, Italy, p.A3653 P999 The Sex-Age Interactions in Pulmonary Arterial Hypertension/ J.A. Groeneveldt, C.E.E. van der Bruggen, P. Trip, B.E. Westerhof, A. Vonk Noordegraaf, F.S. De Man, Amsterdam, Netherlands, p.A3654 Facilitator : E. Brittain, MD, Nashville, TN P1000 Changes in Pulmonary Hemodynamics During Right Heart Catheterization in Pulmonary Hypertension/ C.A. Melillo, J. Lane, K.S. Aulak, R.A. Dweik, A.R. Tonelli, Cleveland, OH, p.A3655 P1001 Risks of Endotracheal Intubation in Decompensated Acute Right Heart Failure/ W. Toppen, A.L. Ramsey, D. Markovic, T.H. Neville, R. Saggar, D. Berlin, I. Barjaktarevic, Los Angeles, CA, p.A3656 P1002 Association Between Tobacco Smoking, Lung Function, Echocardiography, and Hemodynamics in Patients with Pulmonary Hypertension/ R.M. Hoffman, C.R. Hill, A. Van, W. Dean, L.A. Saketkoo, S. Saito, B.P. deBoisblanc, S.P. Kantrow, M.R. Lammi, New Orleans, LA, p.A3657 P1003 The Effects of Pulmonary Hypertension with Left-Sided Heart Disease on Outcomes in Renal Transplant Patients/ R. Holden, P. Vasanth, A. Trammell, M.R. Fisher, Atlanta, GA, p.A3658 Facilitator : M. Simon, MD, Pittsburgh, PA P1004 Prognostic Value of the Six-Minute Walk Test in Young Patients with Pulmonary Arterial Hypertension/ B. Vickers, S.J. Halliday, A. Hemnes, Nashville, TN, p.A3659 P1005 Transcultural Adaptation in a Colombian Population of the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR) in Patients with Pulmonary Hypertension/ C. Villaquiran-Torres, S. Moreno-Luna, R. Duenas, J. Lutz-Pena, P. Acuna, Bogotá, Colombia, p.A3660 P1006 Pulmonary Veno-Occlusive Disease in Elderly Patients with Hypoxemia Out of Proportion to Underlying Pulmonary or Cardiovascular Disease: An Under-Recognized Entity?/ L.N.P. Benjamin, J.M. Rodriguez-Lopez, A.S. Witkin, R.N. Channick, Boston, MA, p.A3661 P1007 Sex-Specific Residual Pulmonary Vasodilative Reserve as Predictors in Patients with Idiopathic Pulmonary Arterial Hypertension Pulmonary Arterial Hypertension/ Y. Yu, S. Gong, P. Yuan, Y.L. Yang, R. Jiang, L. Wang, W.H. Wu, W. Xie, J. Liu, Nanjing, China, p.A3662 BASIC • CLINICAL • TRANSLATIONAL THEMATIC POSTER SESSION B56 LET’S GET PHYSICAL: EXERCISE AND BIOMECHANICS OF PAH 9:15 a.m. - 4:15 p.m. KBHCCD Area G (Hall F, Level 2) Viewing: Posters will be on display for entire session. Discussion: 11:15-12:00: authors will be present for individual discussion 12:00-1:00: authors will be present for discussion with assigned facilitators. Facilitators : N.C. Chesler, PhD, Madison, WI R.R. Vanderpool, BS, MS, PhD, Tucson, AZ P1009 Heart Rate Expenditure During 6MW Correlates with Right Ventricular Function/ D. Lachant, A. Light, R.J. White, Rochester, NY, p.A3663 P1010 Main Pulmonary Artery Dilation in Early/Exercise Pulmonary Hypertension/ N. Ruopp, I. De La Bruere, I. Singh, C.E. Come, M. Faria Urbina, J. Leopold, G.R. Washko, R. San Jose Estepar, D.M. Systrom, A.B. Waxman, F.N. Rahaghi, Boston, MA, p.A3664 P1011 Invasive CPET to Evaluate Pulmonary Vascular Limitation in Patients with Scleroderma ILD and Pulmonary Hypertension/ M. Insel, R.R. Vanderpool, F.P. Rischard, Tucson, AZ, p.A3665 P1012 The Association of Systemic Vascular Properties with Right Ventricular Function in Patients with Pulmonary Hypertension/ R. Goodman, B. Ky, V. Narasimhan, J.A. Mazurek, A. Smith, H.I. Palevsky, J.S. Fritz, C.L. Archer-Chicko, M. Patel, D. Pinder, K. Boyle, S. Pugliese, C. Burwell, J.A. Chirinos, S.M. Kawut, N. Al-Naamani, Philadelphia, PA, p.A3666 P1013 The Spatial Scale of Pulmonary Vascular Fractal Behavior in Pulmonary Arterial Disease/ R.C. Sa, B.J.P. Pazar, A.R. Elliott, G.K. Prisk, R.J. Theilmann, S.R. Hopkins, La Jolla, CA, p.A3667 Facilitators : M.B. Brown, PT, PhD, Indianapolis, IN D. Valdez-Jasso, PhD, La Jolla, CA P1014 Pulmonary Vascular Distensibility and Early Pulmonary Vascular Remodelling in Pulmonary Hypertension/ I. Singh, R. Oliveira, R. Naeije, F.N. Rahaghi, W.M. Oldham, D.M. Systrom, A.B. Waxman, New Haven, CT, p.A3668 P1015 Exercise Pulmonary Hypertension in Interstitial Lung Disease/ K.J. Henry, L. Gargani, S. Sultan, R. Saggar, E. Bossone, R. Saggar, Phoenix, AZ, p.A3669 P1016 Volume Challenge in Occult Pulmonary Venous Hypertension: A Systematic Review of the Literature/ N. Schoenberg, N. Ruopp, K.C. Wilson, H.W. Farber, Boston, MA, p.A3670 ATS 2019 • Dallas, TX MONDAY • MAY 20 175 MONDAY MORNING